FGF-23 Correlates with Endocrine and Metabolism Dysregulation, Worse Cardiac and Renal Function, Inflammation Level, Stenosis Degree, and Independently Predicts In-Stent Restenosis Risk in Coronary Heart Disease Patients Underwent Drug-Eluting-stent PCI
BMC cardiovascular disorders（2021）
关键词
Fibroblast growth factor 23,In-stent restenosis,Drug-eluting stent,Coronary heart disease,Risk factors
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要